English
Français
Deutsch
Italiano
Polski
Português
Русский
Español
ไทย
Türkçe
简体中文
हिन्दी
日本語
By Adriano Marchese
Aurora Cannabis said Tuesday that it has resolved its patent litigation with synthetic biology company Willow Biosciences.
The Canadian cannabis company said it completed a confidential settlement which resolved a patent litigation between the two companies in Canada.
Aurora first began its patent-infringement action in July of 2021, alleging that Willow’s biosynthetic process for synthesizing cannabinoids infringed Aurora’s exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council.
No other details of the settlement were disclosed.
Write to Adriano Marchese at [email protected]
Read the full article here
